Role of Jak1 in atherosclerosis in Tet2 clonal hematopoiesis
Description: TET2 clonal hematopoiesis (CH) is one of the most common CH variants and associated with substantial cardiovascular disease (CVD) risk. TET2 deficiency leads to a progressive expansion of myeloid cells and inflammatory changes in macrophages. TET2 CH increases atherosclerosis involving macrophage NLRP3 inflammasome activation, IL-1b production and increased IL-6 signaling. TET2 deficiency has also been implicated in the expansion of memory and chimeric antigen receptor (CAR) T cells in humans and mice but role of T cell deficiency of Tet2 in atherosclerosis has not been examined. JAK1 is a critical effector of pro-inflammatory cytokine signaling in multiple pathways including in macrophages and T cells. My preliminary studies have shown that pan-hematopoietic Jak1 deficiency in Tet2 CH/Ldlr-/- markedly reduces NLRP3 inflammasome activation and atherosclerosis. Unexpectedly, there was an expansion of CD8 T cells, increased IFNg staining and increased expression of MHCII on macrophages in lesions of Tet2 deficient mice with reversal by Jak1 deficiency. Preliminary studies suggest a role of IFNg in non-transcriptional priming of the NLRP3 inflammasome in macrophages. The goal of this proposal is to evaluate the role of macrophage or CD8 T cell deficiency of Tet2 in the promotion of atherosclerosis and the impact of Jak1 deficiency in reversing macrophage versus T cell changes. I will use Cd8aCre to effect CD8 T cell specific Tet2 and/or Jak1 deletion in Ldlr-/- mice and then assess atherosclerosis and inflammatory markers such as IFNg, IL-1b and cleaved Gasdermin D in atherosclerotic plaques. scRNAseq will be employed on CD45+ aortic cells to profile changes in lymphocyte and macrophage populations associated changes in expression of inflammatory genes such as IFNg and MHC-II in response to Tet2 deletion and Jak1 deficiency in CD8 T cells. I will use Cx3cr1Cre to mediate macrophage-specific Tet2 and/or Jak1 deletion in Ldlr-/- mice and assess atherosclerosis and inflammatory markers in plaques. These proposed studies are expected to provide better mechanistic understanding of the role of Tet2 mutation in CD8 T cells versus macrophages and their crosstalk in Tet2 CH atherosclerosis.
Funder: American Heart Association
Amount: $161,200
Funding type: fellowship
Funder scheme: Postdoctoral Fellowship
Start date: 2025-01-01
End date: 2026-12-31
Investigator: Ranran Wang (lead)
Institutions: Columbia University, The Trustees of Columbia University in the City of New York
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Funded outputs count: 0
Funder award ID: 25POST1374440
OpenAlex ID: G5656295929
